• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

I'm Taking Cover in Cash, Small Biotech Plays Before Big News Hits

We've got two inflation-related reports landing next week and the Fed rate decision. Here's my take on how to handle the unpredictable time.
By JAMES "REV SHARK" DEPORRE
Dec 08, 2022 | 11:48 AM EST
Stocks quotes in this article: ATNM, TGTX

We have some random, but positive action as investors position in front of important economic news. The producer price index report lands Friday and then the consumer price index report arrives on Tuesday. The Fed interest rate decision and a press conference with chair Jerome Powell will hit the market on Wednesday. 

The mood has grown increasingly bearish this week as the focus has shifted from consumer inflation to strong employment and growing worries about a recession. Strategists have been negative about what will happen in 2023, and the market has lost its excitement about peak inflation and a slightly less hawkish Fed.

There is potential for a favorable reaction to the PPI, CPI, and the Fed, and with the market giving back all the gains created by Powell's last speech, the technical setup is favorable, but there is a risk of hot numbers again, which would cause a brutal response.

If the market can navigate these events, then we will have good conditions into the end of the year. Positive seasonality could still come into play. Seasonality is a tendency and not a certainty, but if the market can navigate some of the macro news, it could be self-fulfilling to some extent.

I've been doing some day trading of indexes and ETFs this morning while keeping in mind that PPI is tomorrow morning.

I see little I want to trade right now, but I see some charts I like in biotechnology, such as Actinium Pharmaceuticals Inc  (ATNM)  and TG Therapeutics Inc common stock (TGTX) , and a few others. This is not a market for building big positions right now, and I will continue to maintain very high cash levels. After the Fed is out of the way next Wednesday, we will be in better shape to build some trades for the last few weeks of the year.

(Please note that due to factors including low market capitalization and/or insufficient public float, we consider some of these stocks to be a small-cap stock. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, DePorre was long ATNM, TGTX.

TAGS: Investing | Stocks | Federal Reserve

More from Stocks

Fast Food Might Offer Investors a Quick Buck

Bob Lang
Feb 7, 2023 5:15 PM EST

Let's see how these restaurants may be settling into a profit sweet-spot amid inflation's ups and downs.

Giddy Market Gets Powell Happy

James "Rev Shark" DePorre
Feb 7, 2023 4:33 PM EST

The euphoric reaction to the Fed among investors makes little sense -- but adds to the market volatility.

When It Comes to Politics and ETFs, If You Can't Beat 'Em, Join 'Em

Mark Abssy
Feb 7, 2023 2:17 PM EST

Surprise! Lawmakers, no matter the party, are not exempt from insider-trading laws, just like the rest of us. But we can all invest in these two new exchange-traded funds.

Is FMC Corp Facing a Downward Correction?

Bruce Kamich
Feb 7, 2023 12:55 PM EST

Let's see what the charts look like.

It's Decision Time for Bulls and the Market

James "Rev Shark" DePorre
Feb 7, 2023 11:45 AM EST

The market is at a very important juncture.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:22 AM EST REAL MONEY

    LIVE EVENT: Bruce Kamich and Todd Campbell Share Their Stock Market Insights

    This Monday, Feb. 6 at 12 p.m., our very own exper...
  • 02:58 PM EST REAL MONEY

    Sarge Guilfoyle Breaks Down the Jobs Report, Fed Policy and Stocks!

    Watch it here!
  • 11:35 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Trading an Irrational Market
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login